why choose us

300×250 Ad Slot

Research Article: Optimizing nursing care in phototherapy to improve treatment outcomes in neonatal jaundice management

Date Published: 2025-12-17

Abstract:
Neonatal jaundice is a common condition affecting many newborns and often requires phototherapy to manage elevated bilirubin levels. This study aimed to evaluate the impact of optimized nursing care during phototherapy on treatment outcomes, investigating common nursing challenges and assessing whether enhanced interventions could accelerate recovery and improve overall effectiveness. A total of 106 neonates with jaundice who underwent phototherapy between January 1 and December 1, 2023, were randomly assigned to a control group and an intervention group, with 53 cases in each. The control group received standard nursing care, while the intervention group received targeted nursing interventions addressing phototherapy-related issues. Relevant clinical and laboratory data were collected from hospital records and nursing assessments, and treatment outcomes were compared between the two groups. The intervention group exhibited significantly shorter times for symptom resolution, complete blood count recovery, first defecation, and meconium transition to yellow compared to the control group ( P <?0.05). Moreover, total and indirect bilirubin levels were significantly lower in the intervention group than in the control group ( P <?0.05), while direct bilirubin showed no significant difference. The rate of adverse nursing events was significantly lower in the intervention group (1.89%) compared to the control group (13.21%) ( P <?0.05). Additionally, the quality-of-care score for the intervention group was significantly higher than that of the control group ( P <?0.05). Enhancing nursing interventions for phototherapy-related issues in neonatal jaundice significantly improves therapeutic outcomes, accelerates recovery, and optimizes the effectiveness of phototherapy.

Introduction:
Neonatal jaundice is a common condition affecting approximately 60% of full-term and 80% of preterm newborns worldwide ( 1 ). The condition is multifactorial, with symptoms typically appearing between the second and eighth day of life. These symptoms are often attributed to immature liver function and impaired bilirubin metabolism, which can lead to serious complications such as bilirubin encephalopathy and kernicterus ( 2 , 3 ). If not properly managed, neonatal jaundice can result in long-term neurological…

Read more

300×250 Ad Slot